Related Experiment Video

Updated: May 8, 2026

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
07:40

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Published on: October 10, 2019

[The basic research on the high-sensitive troponin I assay, and the application to evaluation of chronic heart

Hiroe Okura, Reiko Suzuki, Yoshiko Azuma

    Rinsho Byori. the Japanese Journal of Clinical Pathology
    |August 17, 2013
    PubMed

    Insights

    A new high-sensitivity cardiac troponin assay (cTnI hs-ARCH) shows promise for predicting chronic heart failure (CHF) prognosis, even in patients with impaired renal function.

    Area of Science:

    • Biomarker discovery
    • Cardiovascular diagnostics
    • Geriatric medicine

    Context:

    • Aging societies face rising heart disease mortality, particularly chronic heart failure (CHF).
    • Current biomarkers like BNP/NT-proBNP aid diagnosis, but cardiac troponin (cTn) shows potential for prognosis.
    • Existing cTn assays lack sensitivity for detecting low levels in CHF patients.

    Purpose:

    • To evaluate a novel high-sensitivity cardiac troponin assay, cTnI hs-ARCH, for its sensitivity and performance in chronic heart failure (CHF) patients.
    • To compare cTnI hs-ARCH with conventional sensitive methods for cTn measurement in CHF.
    • To assess the utility of cTnI hs-ARCH in predicting CHF prognosis, considering factors like renal function.

    Summary:

    • A new high-sensitivity assay, cTnI hs-ARCH, demonstrated superior sensitivity compared to two conventional methods.
    • In CHF patients, cTnI hs-ARCH effectively discriminated between New York Heart Association (NYHA) functional classes.
    • Multivariable analysis indicated cTnI hs-ARCH is minimally affected by renal function, unlike other methods.

    Impact:

    • cTnI hs-ARCH offers improved prognostic evaluation for CHF patients, a growing concern in aging populations.
    • The assay's robustness in the presence of renal impairment makes it valuable for a significant CHF patient subgroup.
    • This advancement could lead to more precise risk stratification and tailored management strategies for chronic heart failure.

    More Related Videos

    A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay10:12

    A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

    Published on: August 8, 2013

    Related Concept Videos

    Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

    Blood Studies for Cardiovascular System I: Cardiac Biomarkers

    Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
    The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
    Troponins
    Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
    Acute Coronary Syndrome III: Diagnostic Studies01:30

    Acute Coronary Syndrome III: Diagnostic Studies

    Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

    Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
    These markers indicate stress or strain on the heart muscle:
    Natriuretic Peptides (BNP)
    Cardiac myocytes produce these hormones in response to ventricular stretching...
    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    Heart Failure I: Introduction01:27

    Heart Failure I: Introduction

    Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

    The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...